Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bjune

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 28, 2003
Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infectionA I El-Sony, A H Khamis, D A Enarson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 22, 2003
The effect of decentralisation on tuberculosis services in three states of SudanA I El-Sony, S A Mustafa, A H Khamis, et al.
NIPH Annals|December 1, 1991
The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosisE A Høiby, G Bjune, L O Frøholm, et al.
Lancet (London, England)|February 24, 2001
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infectionR Hernández-Pando, M Jeyanathan, G Mengistu, et al.
Infection and Immunity|December 1, 1995
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineE Rosenqvist, E A Høiby, E Wedege, et al.
Problemy Tuberkuleza I Boleznei Legkikh|November 11, 2005
[Impact of drug resistance of the causative agent on the outcomes of treatment for pulmonary tuberculosis in the Arkhangelsk Region]O S Tungusova, N I Nizovtseva, T V Toichkina, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2003
Symptoms in patients attending services for diagnosis of pulmonary tuberculosis in SudanA I El-Sony, S A Mustafa, A H Khamis, et al.
Microbial Pathogenesis|September 1, 1997
Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine developmentS Rune Andersen, J Kolberg, E A Høiby, et al.
NIPH Annals|December 1, 1991
Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studiesE Rosenqvist, E A Høiby, G Bjune, et al.
Journal of Clinical Microbiology|February 1, 1994
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled populationD A Caugant, E A Høiby, P Magnus, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 28, 2003
Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infectionA I El-Sony, A H Khamis, D A Enarson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 22, 2003
The effect of decentralisation on tuberculosis services in three states of SudanA I El-Sony, S A Mustafa, A H Khamis, et al.
NIPH Annals|December 1, 1991
The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosisE A Høiby, G Bjune, L O Frøholm, et al.
Lancet (London, England)|February 24, 2001
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infectionR Hernández-Pando, M Jeyanathan, G Mengistu, et al.
Infection and Immunity|December 1, 1995
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineE Rosenqvist, E A Høiby, E Wedege, et al.
Problemy Tuberkuleza I Boleznei Legkikh|November 11, 2005
[Impact of drug resistance of the causative agent on the outcomes of treatment for pulmonary tuberculosis in the Arkhangelsk Region]O S Tungusova, N I Nizovtseva, T V Toichkina, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2003
Symptoms in patients attending services for diagnosis of pulmonary tuberculosis in SudanA I El-Sony, S A Mustafa, A H Khamis, et al.
Microbial Pathogenesis|September 1, 1997
Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine developmentS Rune Andersen, J Kolberg, E A Høiby, et al.
NIPH Annals|December 1, 1991
Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studiesE Rosenqvist, E A Høiby, G Bjune, et al.
Journal of Clinical Microbiology|February 1, 1994
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled populationD A Caugant, E A Høiby, P Magnus, et al.
Pageof 10